Global Bone Marrow Transplantation Analysis and Market Growth, Trend, Research, Study and Forecast 2014
Albany, NY (PRWEB) February 18, 2014 -- Global Markets Directs, 'Bone Marrow Transplantation Pipeline Review, H1 2014', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Bone Marrow Transplantation, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Bone Marrow Transplantation. Bone Marrow Transplantation Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team.
Browse Complete report with TOC : http://www.marketresearchreports.biz/analysis-details/bone-marrow-transplantation-pipeline-review-h1-2014.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
• A snapshot of the global therapeutic scenario for Bone Marrow Transplantation.
• A review of the Bone Marrow Transplantation products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
• Coverage of products based on various stages of development ranging from discovery till registration stages.
• A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
• Coverage of the Bone Marrow Transplantation pipeline on the basis of route of administration and molecule type.
• Key discontinued pipeline projects.
• Latest news and deals relating to the products.
To Download Sample Report Visit : http://www.marketresearchreports.biz/sample/sample/187343.
Reasons to buy
• Identify and understand important and diverse types of therapeutics under development for Bone Marrow Transplantation.
• Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
• Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
• Devise corrective measures for pipeline projects by understanding Bone Marrow Transplantation pipeline depth and focus of Indication therapeutics.
• Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
• Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.
To buy this Report : http://www.marketresearchreports.biz/analysis/187343.
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Bone Marrow Transplantation Overview
Therapeutics Development
Pipeline Products for Bone Marrow Transplantation - Overview
Pipeline Products for Bone Marrow Transplantation - Comparative Analysis
Bone Marrow Transplantation - Therapeutics under Development by Companies
Bone Marrow Transplantation - Therapeutics under Investigation by Universities/Institutes
Bone Marrow Transplantation - Pipeline Products Glance
Late Stage Products
Clinical Stage Products
Early Stage Products
Bone Marrow Transplantation - Products under Development by Companies
Bone Marrow Transplantation - Products under Investigation by Universities/Institutes
Bone Marrow Transplantation - Companies Involved in Therapeutics Development
Mesoblast Limited
Cleveland BioLabs, Inc
Pluristem Therapeutics Inc.
Spectrum Pharmaceuticals, Inc
TikoMed AB
Bone Marrow Transplantation - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Assessment by Therapeutic Class
Drug Profiles
Allogeneic MPC For Bone Marrow Transplantation - Drug Profile
Product Description
Mechanism of Action
R&D Progress
melphalan - Drug Profile
Product Description
Mechanism of Action
R&D Progress
TM-400 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
PLX-BMP - Drug Profile
Product Description
Mechanism of Action
R&D Progress
CBLB-612 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
CBLB-612 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Perforin Inhibitor - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Bone Marrow Transplantation - Recent Pipeline Updates
Bone Marrow Transplantation - Dormant Projects
Bone Marrow Transplantation - Discontinued Products
Bone Marrow Transplantation - Product Development Milestones
Featured News & Press Releases
Nov 13, 2013: Improved Survival In Children With Life Threatening Graft Versus Host Disease Reported After Treatment With Mesoblast\'s Cell Therapy
Nov 04, 2013: Enlivex Therapeutics Publishes Positive Results from Phase I/II Clinical Trial for the Treatment of Bone Marrow Transplant Recipients
Oct 29, 2013: Pharmalink Receives US Orphan Drug Designation for Busulipo, its Novel Oncology Product for Bone Marrow Transplantation
Sep 03, 2013: BioLineRx Announces Issuance of United States Patent Covering Use of BL-8040 for Obtaining Stem Cells
May 07, 2013: Pluristem Develops PLX-RAD Cells For Use In Hematology
Dec 05, 2012: URMC Researchers Test New Approach To Accelerate Blood Stem Cells
Nov 06, 2012: Cleveland BioLabs Announces Publication Of Studies On Effect Of Entolimod On Graft-versus-tumor Activity In Models Of Allogeneic Bone Marrow Transplantation
Oct 24, 2012: Enlivex Therapeutics Completes Clinical Trial For Treatment Of Bone Marrow Transplant Recipients, Reports Positive Results
Sep 05, 2012: Pluristem Therapeutics Announces Successfully Treatment Of Third Critically Ill Patient With PLX Cells Under Compassionate Use
Aug 06, 2012: Pluristem\'s PLX Cells Save Life Of Cancer Patient Suffering From Bone Marrow Failure
Contact US:
Office: United States
State Tower
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
E: sales(at)marketresearchreports(dot)biz
Blog: http://mresearchreports.blogspot.com
Michell Thoras, Market Research Reports, http://www.marketresearchreports.biz/, +1 (518) 618-1030, [email protected]
Share this article